Concomitant transthyretin cardiac amyloidosis in patients undergoing TAVR for aortic stenosis: A systemic review and meta-analysis

This publication has 33 references indexed in Scilit:

• Could Late Enhancement and Need for Permanent Pacemaker Implantation in Patients Undergoing TAVR Be Explained by Undiagnosed Transthyretin Cardiac Amyloidosis?
  JACC, 2015
• Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation
  European Heart Journal, 2014
• Cardiac Amyloidosis as a Potential Risk Factor for Transapical Transcatheter Aortic Valve Implantation
  Journal of Cardiac Surgery, 2014
• Outcomes of Transcatheter and Surgical Aortic Valve Replacement in High-Risk Patients With Aortic Stenosis and Left Ventricular Dysfunction
  Circulation: Cardiovascular Interventions, 2013
• Pathology of Transcatheter Valve Therapy
  JACC: Cardiovascular Interventions, 2012
• Embolic Cerebral Insults After Transapical Aortic Valve Implantation Detected by Magnetic Resonance Imaging
  JACC: Cardiovascular Interventions, 2010
• The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
  Journal of Clinical Epidemiology, 2009
• Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation inalpha2‐macroglobulinandtau: A population‐based autopsy study
  Annals of Medicine, 2008
• Measuring inconsistency in meta-analyses
  BMJ, 2003
• Publication and related bias in meta-analysis
  Journal of Clinical Epidemiology, 2000